Latest News

Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.


Often Lasting Twice as Long as Any Other Neurotoxin on the Market, Daxxify Makes Its US Debut

InStyle Logo

What You Should Know About Daxxify, the New Botox Alternative

Nashville Post Logo

Aesthetics Company Appoints Chief Medical Officer

Practical Dermatology Logo

A Growing Neuromodulator Market: Daxxify Approved


Daxxify Is The New Injectable You’re Going To See Everywhere in 2023

Practical Dermatology Logo

Two New Studies Highlight the Efficacy and Safety Profile of Revance’s DAXXIFY


Meet Daxxify, a New Botox Alternative That Was Just Approved by the FDA

Allure Logo

What Is Daxxify, and Why Would I Want to Inject It in My Face

Modern Aesthetics logo

FDA Approves Daxxify from Revance

Dermatology Times logo

FDA Approves Daxibotulinumtoxin A for Injection for Glabellar Lines

NewBeauty Logo

The Latest News In The World of Injectable Fillers